MMGP MM2 GROUP INC A DL - 500 Beiträge pro Seite

[griechischdenken]

Der Nächste Knaller nach IYAS?

Im Moment mit run 200% und steigt.
News:
MMGP $0.011 $0.0079 (%254.84)

LIVINGSTON, N.J., Nov. 27 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) reported on November 19, 2007, in a Form 10-QSB filing with the Securities and Exchange Commission, net income of $951,855 for the quarter ending September 30, 2007, which is the first quarter of fiscal 2008 for the Company. In the same time period last year, the Company reported a loss of $1,379,761.

Total sales for the three months ended September 30, 2007 and 2006 were $691,925 and $26,141, respectively. The increase in sales in 2007 was derived from the sales of nutritional supplements and vitamins by Genotec.

Total other (income) expense for the three months ended September 30, 2007 was an income of $1,236,773. This total was comprised of a gain on revaluation of derivatives of $1,563,953, consulting income of $70,000 and interest income of $5,050. These amounts are offset by amortization of the discount on debt conversion of $223,344, liquidated damages of $114,029, interest expense of $47,957 and beneficial interest expense of $16,900 due to the difference between value of the consulting fees and the fair value of the stock at the date of issuance. Loss from operations for the three months ended September 30, 2007 equaled $284,918 versus a loss of $202,182 in the same period last year.

This financial performance is a record in the history of the MM2 Group.


Mark Meller, CEO of MM2 Group, commented, \"We are proud to report these results for the first quarter of 2008. The management team at Genotec Nutritionals, our wholly-owned subsidiary, is doing an excellent job of delivering great results.\"

Meller continued, \"Business is excellent across the board. Our high potency fish oil soft gels continue to sell very well. Our cardiac care line, which is in beta testing at select outlets, shows very exciting potential. Our Sugarest(TM) diet product has captured the imagination of the news media throughout the United States, where it has been featured on over 100 television news programs on every major network in the country, and was even featured on ABC\'s national news program, Good Morning America. We look forward to continuing to deliver superior results throughout the rest of the year. Shareholders should read the complete details of our first quarter results in the Company\'s recently filed Form 10-QSB.\"

About MM2 Group, Inc.

MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The Company\'s growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at [phone] or by e-mail at [e-mail] or Jerry Mahoney at [e-mail].

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as \"believe,\" \"expect,\" \"anticipate,\" \"should,\" \"planned,\" \"will,\" \"may,\" \"intend,\" \"estimated,\" and \"potential,\" among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

SOURCE MM2 Group, Inc.


Heute noch auf die ,02??

[griechischdenken]

Doppelt soviele Käufe, wie Verkäufe.
Das Ding läuft sich warm

[griechischdenken]

Antwort auf Beitrag Nr.: 32.583.966 von griechischdenken am 27.11.07 16:59:59

sehe gerade: IYSA soll heißen

[VanDycke]

Antwort auf Beitrag Nr.: 32.584.097 von griechischdenken am 27.11.07 17:08:16

rt chart bitte ?

[papschy]

Antwort auf Beitrag Nr.: 32.584.442 von VanDycke am 27.11.07 17:29:42

Bitte sehr

[VanDycke]

danke

[papschy]

Antwort auf Beitrag Nr.: 32.584.818 von VanDycke am 27.11.07 17:55:56

Scheint hier heute richtig ab zu gehen .Warten wir mal ab wenn die US Boy´s vom Lunch wieder kommen .

[papschy]

Antwort auf Beitrag Nr.: 32.584.887 von papschy am 27.11.07 18:01:20

So wir können starten Bid 0,0095 Ask 0,01

[papschy]

Antwort auf Beitrag Nr.: 32.585.903 von papschy am 27.11.07 19:04:55

[papschy]

Antwort auf Beitrag Nr.: 32.585.917 von papschy am 27.11.07 19:05:50

Gesünder kann es nicht nach oben gehen .Bei 0,012 steht die Mauer
wenn die gebrochen wird she ich einen Schlußkurs von über 0,02 Cent.

[griechischdenken]

Bid 125; ask 13

[papschy]

Antwort auf Beitrag Nr.: 32.588.739 von griechischdenken am 27.11.07 21:08:39

So das schütteln ist vorbei Jetzt kann es Richtung 0,02 gehen .

[mal_x]

super news freitag...

[Exploser]

Antwort auf Beitrag Nr.: 32.644.080 von mal_x am 03.12.07 10:48:14

stell mal rein bitte!

[mal_x]

Antwort auf Beitrag Nr.: 32.644.627 von Exploser am 03.12.07 11:34:35

MM2 Group Closes $1.1 Million Sale

LIVINGSTON, N.J., Nov. 30 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has closed on a very large order for high potency odorless fish oil softgels.

The transaction is valued at over $1,100,000, which is to be delivered over the next 7 months.

Fish oil is known for being rich in unsaturated fatty acids and provides essential Omega-3 fatty acids (EPA and DHA). Fish oil may help reduce or inhibit risk factors involved in cardiovascular disease, cognitive decline, macular degeneration, as well as inflammatory and immune disorders. Omega-3 fatty acids also help prevent menopausal symptoms, promotes better circulation and neural development, and lowers cholesterol and triglycerides.

Mark Meller, CEO of MM2 Group, stated, 'Genotec is committed to providing cutting edge products to the market in a timely fashion. This order is among the largest in the Company's history, and rapidly accelerates our growth plan. We have successfully positioned Genotec to grow into a very large company in the near future.'

About MM2 Group, Inc.

MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at [phone] or by e-mail at [e-mail] or Jerry Mahoney at [e-mail].

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as 'believe,' 'expect,' 'anticipate,' 'should,' 'planned,' 'will,' 'may,' 'intend,' 'estimated,' and 'potential,' among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

SOURCE MM2 Group, Inc.

Source: PR Newswire (November 30, 2007 - 9:10 AM EST)

News by QuoteMedia
www.quotemedia.com

[mal_x]

Antwort auf Beitrag Nr.: 32.645.713 von mal_x am 03.12.07 13:11:44

das letzte quartal war auch nicht schlecht...

http://www.mm2group.net./news/112607Q1Results.pdf

[lordmare]

[lordmare]

MM2 Group Closes Sale for New Venture in China
Transaction Valued at $170,000

LIVINGSTON, N.J., April 15 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has closed on a sale for the manufacture of fish oil sofgels. The sofgels will be manufactured in China at the plant of Genotec's joint venture partner.

The customer is one of the largest companies in the nutraceutical industry. While the transaction is initially valued at roughly $170,000, it is anticipated that this order can become a monthly or bi-monthly order, depending upon the customer's satisfaction with the initial shipment.

The current capacity of the state of the art plant is 1.5 billion capsules per year. The plant was designed and built according to the latest cGMP requirements, in full compliance with both U. S. and China standards. The plant is capable of expanding capacity to 5 billion sofgel capsules per year.

George Kontonotas, President of Genotec, stated, 'We are very excited about this venture. The plant is a China SFDA certified facility that complies with cGMP manufacturing standards. These high standards, which allow the plant to currently manufacture pharmaceuticals, make this among the highest quality plants which can be found manufacturing products in the nutritional supplement marketplace.'

Mark Meller, CEO of MM2 Group, commented, 'This is just the first step in our plan. Following the completion of this order, we will have one of the largest and most prestigious companies in the industry as a reference-able customer. As a result, we expect that other, smaller companies will jump in line to take advantage of our cost competitive and high quality products. We hope to be in a position to make several exciting announcements in the near future regarding sales activity from this new venture.'

About MM2 Group, Inc.

MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at [phone] or by e-mail at [e-mail] or Jerry Mahoney at [e-mail].

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as 'believe,' 'expect,' 'anticipate,' 'should,' 'planned,' 'will,' 'may,' 'intend,' 'estimated,' and 'potential,' among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

SOURCE MM2 Group, Inc.



Source: PR Newswire (April 15, 2008 - 9:47 AM EDT)

News by QuoteMedia
www.quotemedia.com

[oski]

0.0021-0.0023 plus 155%

[lordmare]

wer am Freitag und gestern gekauft hat, der hat es gewusst

[oski]

0.0025-0.0027 plus 177%

[oski]

0.0027-0.0028 plus 211%

[oski]

TA email update on MMGP

Date: Mon, 14 Apr 2008 05:48:36 PM EDT

Matt:

The share structure for MM2 Group, Inc. is:

Outstanding: 226,216,161
Restricted: 139,242,644
Float: 86,973,517
Authorized: 450,000,000

[lordmare]

Antwort auf Beitrag Nr.: 33.890.702 von oski am 15.04.08 18:09:44

danke

[lordmare]

[oski]

Antwort auf Beitrag Nr.: 33.891.341 von lordmare am 15.04.08 19:17:23

bitte

[oski]

0.0044 plus 388%

[oski]

Thanks for the chart MOMO. Look at the huge turn in the CMF and the accum/dist huge straight line. Also the CMF took a huge turn north. Also the one indicator that I REALLY like to follow is the TRIX and that shot straight up as well. You take all this on the chart into effect and the fact that no dilution was confirmed after the bell today. This is going much higher. I think this one has had very nice revenue. Some nice contracts and the OS has only gone up about 20 million since the last run. Its very undervalued. The last run took us to almost .02 or so. Also the last run was only about half the volume. I really think todays volume was some buying for something else to come. I would not be shocked to see more news very soon. I mean hell look at EESO they are only really announcing new contract and they have had a hell of a run. We have already had some nice contracts in place that are already producing revenue and just singed a big one that could be huge going forward. The buying on this was freaking huge today there is no doubt about it. You watch i bet this gaps to .0033-.0034 tomorrow morning and we see .004 very soon after the open.

[lordmare]

Antwort auf Beitrag Nr.: 33.894.154 von oski am 16.04.08 06:20:54

Guten Morgen
woher hast du das?
Danke im Voraus

MfG lordmare

[lordmare]

MM2 Group Provides Additional Quotes for New Venture in China
Additional Large Transactions in the Pipeline

LIVINGSTON, N.J., April 17 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has quoted on several large transactions for the manufacture of fish oil sofgels. The sofgels will be manufactured in China at the plant of Genotec's joint venture partner.

The potential customers are second tier (in terms of size) companies in the nutraceutical industry. The transactions, as quoted, are valued at between $136,000 to $204,000 per month.

The current capacity of the state of the art plant is 1.5 billion capsules per year. The plant was designed and built according to the latest cGMP requirements, in full compliance with both U. S. and China standards. The plant is capable of expanding capacity to 5 billion sofgel capsules per year.

Mark Meller, CEO of MM2 Group, commented, 'We don't typically announce quotes, as opposed to orders. However, the level of activity for new sales quotes in the days since we announced our order with a major player in the industry has prompted us to release this update. Our plan seems to be working. Having closed a deal with one of the largest and most prestigious companies in the industry, other, smaller companies are looking to us to take advantage of our cost competitive and high quality products. What's exciting is that these transactions are only for a single product, whereas we can manufacture many other products like Vitamin E sofgels. The market opportunity is huge. We hope to be in a position to make several exciting announcements in the near future regarding sales activity from this new venture.'

[lordmare]

Outstanding: 246,771,717

Restricted: 149,298,200

Float: 97,473,517

Restricted: 450,000,000


Stand: 16.04.08

[lordmare]

Universal Detection Technology Receives Purchase Order for Hand Held Assays From Israeli Company
Hand Held Assays Used for Detection of Anthrax Sold to Israeli Company

LOS ANGELES, April 23, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (OTCBB:UDTT) (Frankfurt:PO8) (www.udetection.com), a developer of early warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that it has received a purchase order from an Israeli company for the Company's Hand Held Assays (HHA).

The Israeli government as well as private security firms are actively improving their preparedness for a bioterror attack as the potential threat of such an attack from terror organizations and states with active biological weapon programs, such as Syria, grows. As an example, large numbers of the Israeli population have received smallpox inoculations.

UDTT's anthrax detection HHAs have provided accurate results to users in the field in as little as three minutes. The assays have been purchased by first responders throughout the country as well as the U.S. Army. The kits are able to detect anthrax spores well below the threshold for an infectious dose.

"We have seen increased interest in our bioterrorism detection kits recently from Israeli security firms and we hope that this trend can open up doors to more international sales of UDTT's HHAs," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.

For more information please visit our website at www.udetection.com or

Email us at [e-mail].

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.

The Universal Detection Technology logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4911

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

CONTACT: Universal Detection Technology
Jacques Tizabi
310-248-3655
[e-mail]


Source: PrimeNewswire (April 23, 2008 - 7:01 AM EDT)

News by QuoteMedia
www.quotemedia.com

[mazuba]

Antwort auf Beitrag Nr.: 33.952.167 von lordmare am 23.04.08 14:52:31

Hi lordmare
solltest du sie nicht bei Udtt reinstellen
Wetter war gut später mehr

[lordmare]

Antwort auf Beitrag Nr.: 33.952.832 von mazuba am 23.04.08 15:45:58

Hallo mazuba

wieso nicht



Gruß

[lordmare]

Antwort auf Beitrag Nr.: 33.955.260 von lordmare am 23.04.08 19:24:56

Outstanding: 284,549,495
Restricted: 187,075,978
Float: 97,473,517
Authorized: 450,000,000

Stand : 29.04.2008

[Reznor]

Aus dem letzten NT 10-Q Filing:

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No

Revenues for the quarter ended March 31, 2008 will equal approximately $685,000 as compared to $247,954 for the same period in fiscal 2007. Net profit for the quarter ended March 31, 2008 will equal approximately $2 million as compared to $254,223 for the same period last fiscal year.

Revenues for the nine months ended March 31, 2008 will equal approximately $1.9 million as compared to $674,230 for the same period last fiscal year. Net profit for the nine months ended March 31, 2008 will equal approximately $1.2 million as compared to a net loss of $1,641,801 for the same period last fiscal year.


Montag wird interessant.

[lordmare]

[Wesley_]

MMGP 10QSB filing gestern veröffentlicht:

http://www.sec.gov/Archives/edgar/data/1141500/0001072613080…

[Reznor]

Bin bei .0017 komplett raus am Montag....

[Saftladen]

[lordmare]

Gut zu wissen:
http://www.wallstreet-online.de/nachrichten/nachricht/246151…

US-Börsenaufsicht SEC schränkt Spekulieren auf fallende Kurse ein
Leser des Artikels: 541

WASHINGTON (dpa-AFX) - Die US-Börsenaufsicht SEC will angesichts der jüngsten Turbulenzen an den Börsen das Spekulieren auf fallende Aktienkurse einschränken. Für den Handel mit den zuletzt massiv unter Druck geratenen Titeln der Hypothekenfinanzierer Fannie Mae und Freddie Mac sowie der US-Investmentbanken sollen vorerst verschärfte Regeln gelten. Das kündigte SEC-Chef Christopher Cox am Dienstag vor dem Bankenausschuss des US-Senats in Washington an.

Kritiker hatten immer wieder beklagt, dass Spekulanten durch Wetten auf fallende Kurse die Notierungen zusätzlich massiv nach unten treiben. Die SEC nimmt nun besonders die immer mehr verbreitete Praxis der Leerverkäufe (shortselling) ins Visier. Dabei verkaufen Investoren Aktien, die sie gar nicht besitzen, sondern sich nur von Dritten gegen Gebühr ausleihen. Sie hoffen dann auf fallende Kurse, um die Titel billiger zurückerwerben und dem Ausleiher wiedergeben zu können. Die Differenz zwischen den Preisen streichen sie als Gewinn ein.

Bisher durften sich mehrere Investoren sogar zeitgleich dieselben Aktien ausleihen. Genau dies soll nun zunächst bei den Aktien von Fannie Mae und Freddie Mac sowie bei Investmentbanken verboten werden. Die SEC erwäge aber auch, die Beschränkungen auf alle Aktien auszudehnen. Dadurch soll der Umfang der Leerverkäufe sinken. Die Börsenpolizei untersucht derzeit, ob die massiven Kurseinbrüche etwa bei der inzwischen an JPMorgan verkauften Investmentbank Bear Stearns und zuletzt bei Lehman Brothers durch missbräuchliche Handelspraktiken beschleunigt wurden./fd/DP/ck

[Saftladen]

[lordmare]

Antwort auf Beitrag Nr.: 34.555.442 von Saftladen am 21.07.08 21:46:31

Der ganze Artikel ist hier:

http://www.manager-magazin.de/geld/artikel/0,2828,567060,00.…





Wie die SEC ein Phantom jagt (2)

Von Marc Pitzke, New York



SEC kämpft gegen Panik und handelt spät

Und so sind sie auch heute wieder das heißeste Gesprächsthema an der Wall Street - als mutmaßliche Hinterleute der Bankenkrise. Die Börsenaufsicht SEC und das US-Finanzministerium jedenfalls sehen das so. Im Kampf gegen die schwelende Panik in den USA hat die SEC gegen eine besonders umstrittene Variante des Leerverkaufs ein Verbot erlassen, das an diesem Montag in Kraft tritt. Untersagt ist künftig das naked short selling.

Nackthandel verboten: An der Wall Street ist der Handel mit "Phantomaktien" künftig tabu



Besonders betroffen davon sind verwundbare Finanzwerte wie die Hypothekenversicherer Fannie Mae und Freddie Mac sowie 17 weitere Wall-Street-Firmen, die auf das Vertrauen der Investoren angewiesen sind, etwa die ramponierten Investmentbanken Merrill Lynch , Morgan Stanley und Lehman Brothers .

"Nackter" Leerhandel ist ein Short Sale ohne konkrete Ware: Aktien werden geshortet, obwohl sich der Händler sie dabei weder leiht noch sie innerhalb der vorgeschriebenen Drei-Tage-Frist wieder zurückerstattet. Im Prinzip handelt er also mit "Phantomaktien", wie es der Wirtschaftskanal "Bloomberg TV" letztes Jahr in einer Sondersendung nannte. Firmenchefs wie Patrick Byrne von der Einzelhandelswebsite Overstock.com protestieren gegen diese Praxis schon lange. Diese Händler seien "Terroristen" und würden "kleine Unternehmen zerstören".

Wer short geht, muss Aktien zeitweise auch besitzen

Nun hat das auch die SEC zur "gesetzwidrigen Manipulation" erklärt - allerdings erst, als große Konzerne ins Wanken gerieten. Alle Händler müssen ab sofort nachweisen, dass sie die Aktien zwischendurch tatsächlich besitzen. "Es ist sehr wichtig", so Finanzminister Henry Paulson - der als Ex-Vorstandschef von Goldman Sachs intime Kenntnis dieser Materie hat - am Sonntag auf CNN, "dass wir das Vertrauen in die Kapitalmärkte wiederherstellen."


Es liest sich wie eine Formalität, doch wird das Verbot das gesamte Short Selling erheblich erschweren. Denn bisher brauchten Trader den Leihprozess generell nicht zu dokumentieren, auch wenn sie ihn einhielten. Jetzt wird nicht nur den "nackten" Leerhändlern, sondern auch allen anderen Sand ins Getriebe gestreut. Seit Bekanntgabe des Verbots vergangene Woche rotiert die gesamte Wall Street, um ihre gut geschmierten, geradezu reflexartigen Arbeitsabläufe der neuen Regel rechtzeitig anzupassen.

Hintergrund dieser drastischen Maßnahme ist die Hypotheken- und Kreditkrise - und die Serie von Bilanzeinbrüchen und Kursverlusten. Das Traditionshaus Bear Stearns ging im März unter, nachdem sich ein Gerücht verselbstständigte, es habe Liquiditätsprobleme. Die SEC fahndet nach den Urhebern dieser Gerüchte, vermutet aber, dass Leerhändler - die an dem Kollaps der Investmentbank verdienten - etwas damit zu tun gehabt haben könnten.

[Agadan]

!

Dieser Beitrag wurde moderiert.